Description:
The Pantheris Catheter series, comprised of both the 8Fr and 7Fr variants, is a lumivascular atherectomy device developed by AVINGER INC. The primary goal of these catheters is to restore blood flow in the peripheral arteries effectively and safely.
What distinguishes the Pantheris Catheter from conventional devices is its integrated real-time optical coherence tomography (OCT). This feature allows unparalleled visibility of the artery from inside, even while removing plaque. This may help doctors to more effectively remove plaque without excessive damage to the artery wall.
With the Pantheris Catheter, targeted plaque excision is achieved while ensuring maximum tissue preservation. This aids in minimizing the risk of restenosis or re-narrowing of the artery post-atherectomy, leading to better long-term outcomes for patients.
Additionally, the 7Fr and 8Fr variants provide physicians with the flexibility to choose the most suitable size for patients based on their unique clinical needs. This tailored approach helps facilitate efficient, patient-centered care.
In summary, the Pantheris Catheter is a pivotal tool in arterial plaque management - bridging the gap between the physician's technical needs and the patient's health outcomes.
... Read moreDescription:
The innovative Pantheris Catheter system developed by Avinger Inc. is a prime example of technological advancement within the medical field, specifically vascular disease diagnosis and treatment. This unique system includes the Pantheris Catheter (8F & 7F) and the Lightbox HS Imaging console with an integrated Lightbox Sled.
Touted as the first-ever set of devices that allow physicians to see and remove plaque simultaneously during an atherectomy procedure(a minimally invasive treatment for peripheral artery disease), the Pantheris Catheter combined with the Lightbox offers significant advantages. The primary benefit of this groundbreaking solution is its ability to improve precision and safety of atherectomy procedures by providing real-time visual guidance to physicians.
The key component of this system is the Pantheris Catheter. It has the capabilities of both viewing arterial walls and removing plaque with a high level of accuracy. The catheters come in two sizes: the Pantheris (8F) and the slightly smaller Pantheris (7F), allowing for versatility depending on the individual patient’s needs.
The accompanying Lightbox HS Imaging Console and the Lightbox Sled enhance this system by providing high-definition, real-time images of the inside of the artery during the procedure. The Lightbox's high resolution and increased imaging depth bring added sophistication and clarity to each procedure, aiding the physician in accurately diagnosing and treating the site of disease.
Overall, the Pantheris Catheter system combined with the Lightbox HS Imaging console enhances the effectiveness of atherectomy procedures, potentially reducing post-operative complications and improving patient outcomes. This comprehensive solution by Avinger Inc. continues to pioneer significant advancements within the medical device landscape.
... Read moreDescription:
The Turbo-Power Laser Atherectomy Catheters, developed by Spectranetics Inc., are innovative medical devices specially constructed to enhance patient outcomes in contemporary vascular interventions. Manufactured in two sizes, 2.0mm and 2.3mm, these devices are primarily designed to treat peripheral artery disease (PAD) and coronary artery disease (CAD). The catheters use laser technology to vaporize atherosclerotic plaque in blood vessels.
The primary advantage of the Turbo-Power Laser Atherectomy Catheters is their ability to effectively eliminate blockages from arterial walls, thus restoring blood flow without causing significant damage to the arterial wall. These cutting-edge catheters offer seamless integration with guidewires and have a bidirectional rotatory movement that optimizes the effect of plaque modification.
The Turbo-Power catheters provide higher precision in comparison to conventional atherectomy devices, as they use an excimer laser which uniquely combines cold ultraviolet energy and high energy levels. This allows the catheters to efficiently break down the molecular bonds of the atherectomized plaque without causing thermal damage to the surrounding tissues.
Utilization of the Turbo-Power Laser Atherectomy Catheters facilitate a safer and more effective alternative for vascular interventions, fostering a more rapid patient recovery and significantly lessening the risk of post-operative complications.
In summary, the Turbo-Power Laser Atherectomy Catheters stand as a testament to Spectranetics Inc.'s commitment to developing state-of-the-art medical devices that aim to drastically improve patient outcomes. These catheters provide a compelling example of scientific innovation, marrying laser technology with vascular intervention techniques to tackle the major health challenges of peripheral and coronary artery disease.
... Read more